Advertisement

Breast Cancer Research and Treatment

, Volume 125, Issue 2, pp 545–551 | Cite as

Relationship between diabetes and risk of second primary contralateral breast cancer

  • Christopher I. Li
  • Janet R. Daling
  • Mei-Tzu C. Tang
  • Kathleen E. Malone
Epidemiology

Abstract

Breast cancer survivors have a substantially higher risk of developing a second primary contralateral breast cancer (CBC) compared to the risk of breast cancer among women in the general population. While data regarding the relationship between diabetes and breast cancer incidence are inconsistent, diabetes is more clearly linked to an elevated risk of all-cause mortality among breast cancer survivors. However, no prior studies have assessed its impact on CBC risk. We assessed the relationship between diabetes, and CBC risk in a population-based nested case–control study consisting of women 40–79 years of age diagnosed with a first primary ER-positive invasive breast cancer. It included 322 women who developed a second primary CBC and 616-matched control women diagnosed only with a first breast cancer. We used conditional logistic regression to quantify associations between diabetes and CBC risk. Compared to women without a history of diabetes, diabetics had a 2.2-fold [95% confidence interval (CI) 1.3–3.6] increased risk of CBC. This risk was more pronounced among women diagnosed with their first breast cancer before age 60 years (odds ratio, OR = 11.5, 95% CI 2.4–54.5), compared to those diagnosed at age 60 years or older (OR = 1.5, 95% CI 0.8–2.7, P for interaction = 0.011). Diabetics diagnosed with breast cancer appear to have an elevated risk of CBC. This is the first study to report this relationship, but if confirmed efforts to insure that diabetic breast cancer survivors are carefully screened for second breast cancers may be warranted.

Keywords

Breast cancer Diabetes Contralateral breast cancer 

Notes

Acknowledgments

This study was supported by the National Cancer Institute (Grant Number R01 CA097271). The authors wish to acknowledge the substantial contributions of Ms. Sarah Taylor and Ms. Heather O’Brien in the conduct of this research study. Other staff member making important contributions to this study are: Elisabeth Beaber, Nancy Blythe, Ann Bradshaw, Kay Byron, Fran Chard, Lora Cox, Diane DeHart, Sue Ellingson, Carolyn Howard, Dick Jacke, Jean Jue, Eileen Louie, Karen Lunna, Charlotte Palmberg, Amanda Phipps, Patty Pride, Babette Siebold, Camille Taylor, Loni Tipton, Vicky Tran, and Michelle Zuanich. Lastly, we want to acknowledge the time and generosity of all of the women who participated in this research.

Conflict of interest statement

None.

References

  1. 1.
    Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764CrossRefPubMedGoogle Scholar
  2. 2.
    Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR, Meier CR (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33:1304–1308CrossRefPubMedGoogle Scholar
  3. 3.
    Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8:855–861PubMedGoogle Scholar
  4. 4.
    Early Breast Cancer Trialists’ Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351:1451–1467CrossRefGoogle Scholar
  5. 5.
    Gonzalez-Angulo AM, Meric-Bernstam F (2010) Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16:1695–1700CrossRefPubMedGoogle Scholar
  6. 6.
    Hirose K, Toyama T, Iwata H, Takezaki T, Hamajima N, Tajima K (2003) Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 4:239–246PubMedGoogle Scholar
  7. 7.
    Key T, Appleby P, Barnes I, Reeves G, Endogenous Hormones and Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616PubMedGoogle Scholar
  8. 8.
    Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862CrossRefPubMedGoogle Scholar
  9. 9.
    Lawlor DA, Smith GD, Ebrahim S (2004) Hyperinsulinaemia and increased risk of breast cancer: findings from the British women’s heart and health study. Cancer Causes Control 15:267–275CrossRefPubMedGoogle Scholar
  10. 10.
    Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349–352CrossRefPubMedGoogle Scholar
  11. 11.
    Nyholm H, Djursing H, Hagen C, Agner T, Bennett P, Svenstrup B (1989) Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab 69:946–949CrossRefPubMedGoogle Scholar
  12. 12.
    Quinn MA, Ruffe H, Brown JB, Ennis G (1981) Circulating gonadotrophins and urinary oestrogens in postmenopausal diabetic women. Aust NZ J Obstet Gynaecol 21:234–236CrossRefGoogle Scholar
  13. 13.
    Srokowski TP, Fang S, Hortobagyi GN, Giordano SH (2009) Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 27:2170–2176CrossRefPubMedGoogle Scholar
  14. 14.
    van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120:1986–1992CrossRefPubMedGoogle Scholar
  15. 15.
    van der Burg B, Rutteman GR, Blankenstein MA, de Laat SW, van Zoelen EJ (1988) Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 134:101–108CrossRefPubMedGoogle Scholar
  16. 16.
    Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111CrossRefPubMedGoogle Scholar
  17. 17.
    Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:s823–s835PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Christopher I. Li
    • 1
  • Janet R. Daling
    • 1
  • Mei-Tzu C. Tang
    • 1
  • Kathleen E. Malone
    • 1
  1. 1.Division of Public Health SciencesFred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations